Cargando…
A Systematic Review of Outcomes Following Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
BACKGROUND: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has increasingly become a significant concern for patients. Focus thus far has been on understanding pathogenesis and establishing treatment pathways. There has been less attention on the assessment of long-term treatmen...
Autores principales: | Sharma, Kavita, Gilmour, Adam, Jones, Georgina, O'Donoghue, Joseph M., Clemens, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634150/ https://www.ncbi.nlm.nih.gov/pubmed/36340855 http://dx.doi.org/10.1016/j.jpra.2022.08.008 |
Ejemplares similares
-
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)
por: Lee, Jun-Ho
Publicado: (2021) -
What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?
por: Lajevardi, Sepehr S., et al.
Publicado: (2022) -
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research
por: Deva, Anand K., et al.
Publicado: (2020) -
Breast lymphomas, breast implants and capsules The timeline of BIA-ALCL with respect to surgical consent: the UK perspective
por: Allison, Keith, et al.
Publicado: (2022) -
Abstract: Epidemiology and Risk Factors for Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in Australia & New Zealand
por: Knight, Robert, et al.
Publicado: (2016)